Literature DB >> 21040725

Sporadic reappearance of minute amounts of hepatitis C virus RNA after successful therapy stimulates cellular immune responses.

Naga Suresh Veerapu1, Sukanya Raghuraman, T Jake Liang, Theo Heller, Barbara Rehermann.   

Abstract

BACKGROUND & AIMS: Several studies have reported hepatitis C virus (HCV) RNA sequences in the circulation after treatment-induced or spontaneous recovery. We investigated whether the HCV RNA represents persistence of HCV infection or reinfection.
METHODS: We studied 117 patients who recovered from HCV infection (98 following therapy and 19 spontaneously). A reverse-transcription polymerase chain reaction assay was used to detect the 5'-untranslated region of HCV. T-cell responses were studied by enzyme-linked immunospot for interferon-γ.
RESULTS: Plasma samples from 15% of treatment-recovered patients and no spontaneously recovered patient tested positive for HCV RNA. Lymphocytes from 3 patients who responded to therapy and 1 who recovered spontaneously tested positive. The frequency of HCV RNA detection in plasma correlated inversely with the time after the end of treatment. Post-treatment HCV 5'-untranslated region sequences matched pretreatment sequences in 85% of cases. T-cell responses were significantly greater at time points with detectable trace amounts of HCV RNA than at time points without detectable HCV RNA (P = .035) and were primarily against nonstructural HCV antigens. The immune hierarchy was preserved over 5 years in patients whose post-treatment HCV RNA sequences matched pretreatment sequences, indicating HCV RNA persistence. An altered immune hierarchy with dominant immune responses, shifting from nonstructural to structural antigens, was observed in a single patient whose post-treatment HCV genotype differed from that of the pretreatment genotype, indicating HCV reinfection.
CONCLUSIONS: Trace amounts of HCV RNA of pretreatment sequence persisted and reappeared sporadically in the circulation within 8 years after recovery from hepatitis C but not thereafter, indicating that patients are cured of HCV infection. Reappearance of HCV RNA induced HCV-specific T-cell responses.
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21040725      PMCID: PMC3399733          DOI: 10.1053/j.gastro.2010.10.048

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  34 in total

1.  Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment.

Authors:  Inmaculada Castillo; Elena Rodríguez-Iñigo; Juan Manuel López-Alcorocho; Margarita Pardo; Javier Bartolomé; Vicente Carreño
Journal:  Clin Infect Dis       Date:  2006-10-05       Impact factor: 9.079

2.  Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus.

Authors:  MinKyung Yi; Yinghong Ma; Jeremy Yates; Stanley M Lemon
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

3.  Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis C.

Authors:  Chihiro Morishima; Timothy R Morgan; James E Everhart; Elizabeth C Wright; Minjun C Apodaca; David R Gretch; Mitchell L Shiffman; Gregory T Everson; Karen L Lindsay; William M Lee; Anna S F Lok; Jules L Dienstag; Marc G Ghany; Teresa M Curto
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

4.  Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.

Authors:  Bart J Veldt; E Jenny Heathcote; Heiner Wedemeyer; Juerg Reichen; W Peter Hofmann; Stefan Zeuzem; Michael P Manns; Bettina E Hansen; Solko W Schalm; Harry L A Janssen
Journal:  Ann Intern Med       Date:  2007-11-20       Impact factor: 25.391

5.  Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.

Authors:  Sarah Maylin; Michelle Martinot-Peignoux; Rami Moucari; Nathalie Boyer; Marie-Pierre Ripault; Dominique Cazals-Hatem; Nathalie Giuily; Corinne Castelnau; Ana Carolina Cardoso; Tarik Asselah; Cyrille Féray; Marie Hélène Nicolas-Chanoine; Pierre Bedossa; Patrick Marcellin
Journal:  Gastroenterology       Date:  2008-05-21       Impact factor: 22.682

6.  Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia.

Authors:  Flavien Bernardin; Leslie Tobler; Irina Walsh; Joan Dunn Williams; Mike Busch; Eric Delwart
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

7.  Immune suppression leading to hepatitis C virus re-emergence after sustained virological response.

Authors:  Amy Lin; Anupama Thadareddy; Michael J Goldstein; Gerond Lake-Bakaar
Journal:  J Med Virol       Date:  2008-10       Impact factor: 2.327

Review 8.  Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity.

Authors:  Liisa K Selin; Michael A Brehm; Yuri N Naumov; Markus Cornberg; Sung-Kwon Kim; Shalyn C Clute; Raymond M Welsh
Journal:  Immunol Rev       Date:  2006-06       Impact factor: 12.988

9.  Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection.

Authors:  Tram N Q Pham; Dawn King; Sonya A Macparland; Jerry S McGrath; S Bharati Reddy; Ford R Bursey; Tomasz I Michalak
Journal:  Gastroenterology       Date:  2007-12-14       Impact factor: 22.682

10.  Antagonistic expression of hepatitis C virus and alpha interferon in lymphoid cells during persistent occult infection.

Authors:  T N Q Pham; P M Mulrooney-Cousins; S E Mercer; S A MacParland; M Inglot; M Zalewska; K Simon; T I Michalak
Journal:  J Viral Hepat       Date:  2007-08       Impact factor: 3.728

View more
  32 in total

1.  Investigation of residual hepatitis C virus in presumed recovered subjects.

Authors:  Kei Fujiwara; Robert D Allison; Richard Y Wang; Patricia Bare; Kentaro Matsuura; Cathy Schechterly; Krishna Murthy; Francesco M Marincola; Harvey J Alter
Journal:  Hepatology       Date:  2012-12-06       Impact factor: 17.425

Review 2.  Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control.

Authors:  Juan-Ramón Larrubia; Elia Moreno-Cubero; Joaquín Miquel; Eduardo Sanz-de-Villalobos
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

3.  Clinical significance of discordant positive hepatitis C virus transcription-mediated amplification following end of treatment response.

Authors:  Anisha Thadani; Jennifer Harley; Jonah Rubin; Edward Lebovics
Journal:  Dig Dis Sci       Date:  2011-07-14       Impact factor: 3.199

4.  Sequence analysis of hepatitis C virus from patients with relapse after a sustained virological response: relapse or reinfection?

Authors:  Koji Hara; Maria M Rivera; Christopher Koh; Mary Demino; Sandra Page; Pothu Raju Nagabhyru; Barbara Rehermann; T Jake Liang; Jay H Hoofnagle; Theo Heller
Journal:  J Infect Dis       Date:  2013-10-14       Impact factor: 5.226

5.  Hepatitis C virus late relapse after sustained virologic response from interferon and ribavirin treatment as confirmed by RNA sequencing.

Authors:  Yidan Lu; Anton Andonov; David K H Wong
Journal:  J Clin Microbiol       Date:  2013-10-30       Impact factor: 5.948

Review 6.  Living in the liver: hepatic infections.

Authors:  Ulrike Protzer; Mala K Maini; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2012-02-24       Impact factor: 53.106

7.  New perspectives in occult hepatitis C virus infection.

Authors:  Vicente Carreño; Javier Bartolomé; Inmaculada Castillo; Juan Antonio Quiroga
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

Review 8.  Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection.

Authors:  Barbara Rehermann; Robert Thimme
Journal:  Gastroenterology       Date:  2018-09-26       Impact factor: 22.682

Review 9.  Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade.

Authors:  Heidi Barth
Journal:  World J Hepatol       Date:  2015-04-18

10.  Longitudinal evaluation of hepatitis C viral persistence in HIV-infected patients with spontaneous hepatitis C clearance.

Authors:  A Rivero-Juarez; A Caruz; L M Real; L Martinez-Dueñas; F J Marquez; M Frias; E Recio; A Gordon; J A Pineda; A Rivero; A Camacho
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-08-09       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.